{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:14:32Z","timestamp":1762866872173,"version":"3.38.0"},"reference-count":24,"publisher":"JLE","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.nephro.2015.12.006","type":"journal-article","created":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T09:04:37Z","timestamp":1466499877000},"page":"215-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Is peritoneal dialysis a therapeutic option for polycystic kidney disease? 15\u00a0years\u2019 experience in a single center"],"prefix":"10.1684","volume":"12","author":[{"given":"Yener","family":"Koc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taner","family":"Basturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer","family":"Sakaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuhal","family":"Atan Ucar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elbis","family":"Ahbap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Sevinc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Sinangil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekrem","family":"Kara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arzu","family":"Ozdemir Kayalar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feyza","family":"Bayraktar Caglayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuncay","family":"Sahutoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuri","family":"Baris Hasbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulkadir","family":"\u00dcnsal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2015.12.006_bib0005","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.nephro.2015.12.006_bib0010","first-page":"S1","article-title":"United States renal data system 2008 annual data report","volume":"53","author":"Collins","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2015.12.006_bib0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ncpneph1037","article-title":"Is peritoneal dialysis a suitable renal replacement therapy in autosomal dominant polycystic kidney disease?","volume":"5","author":"Goffin","year":"2009","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.nephro.2015.12.006_bib0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/089686080302300306","article-title":"Risk factors for abdominal wall complications in peritoneal dialysis patients","volume":"23","author":"Del Peso","year":"2003","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.nephro.2015.12.006_bib0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/000313480006600218","article-title":"Diverticulitis and polycystic kidney disease","volume":"66","author":"Lederman","year":"2000","journal-title":"Am Surg"},{"key":"10.1016\/j.nephro.2015.12.006_bib0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/089686089801800414","article-title":"CAPD in patients with autosomal dominant polycystic kidney disease","volume":"18","author":"Hadimeri","year":"1998","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.nephro.2015.12.006_bib0035","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/ki.2008.352","article-title":"Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis","volume":"74","author":"Kumar","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.12.006_bib0040","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5414\/CNP57208","article-title":"Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival","volume":"57","author":"Abbott","year":"2002","journal-title":"Clin Nephrol"},{"issue":"Suppl 4","key":"10.1016\/j.nephro.2015.12.006_bib0045","doi-asserted-by":"crossref","first-page":"iv15","DOI":"10.1093\/ndt\/gfu017","article-title":"Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival \u2013\u00a0an analysis of data from the ERA-EDTA Registry","volume":"29","author":"Spithoven","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.12.006_bib0050","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.ajkd.2011.01.019","article-title":"Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease","volume":"c57","author":"Li","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2015.12.006_bib0055","article-title":"Peritoneal dialysis can be an option for dominant polycystic kidney disease: an observational study","author":"Janeiro","year":"2014","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.nephro.2015.12.006_bib0060","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2014.120","article-title":"Analysis of data from the ERA-EDTA registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease","author":"Spithoven","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.12.006_bib0065","first-page":"336","article-title":"Patients on peritoneal dialysis with type\u00a02 diabetes present poorer progress than non-diabetics at the expense of their cardiovascular co-morbidity","volume":"29","author":"Portol\u00e9s","year":"2009","journal-title":"Nefrologia"},{"key":"10.1016\/j.nephro.2015.12.006_bib0070","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1681\/ASN.V381501","article-title":"Serum albumin in patients on continuous ambulatory peritoneal dialysis-predictors and correlations with outcomes","volume":"3","author":"Blake","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2015.12.006_bib0075","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1093\/ndt\/gfq712","article-title":"Peritoneal dialysis in polycystic kidney disease patients. Report from the French peritoneal dialysis registry (RDPLF)","volume":"26","author":"Lobbedez","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.12.006_bib0080","first-page":"441","article-title":"Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model","volume":"31","author":"Portol\u00e9s","year":"2011","journal-title":"Nefrologia"},{"key":"10.1016\/j.nephro.2015.12.006_bib0085","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/eurheartj\/eht065","article-title":"Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"34","author":"Hou","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nephro.2015.12.006_bib0090","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/0000605-200912150-00162","article-title":"Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin\u00a0II-receptor blockers for ischemic heart disease","volume":"151","author":"Baker","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nephro.2015.12.006_bib0095","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.ajkd.2011.01.023","article-title":"Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population-based study","volume":"57","author":"Patch","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2015.12.006_bib0100","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(13)61451-8","article-title":"Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial","volume":"382","author":"Wiviott","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2015.12.006_bib0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/089686080202200113","article-title":"Polycystic kidney disease and late peritoneal leakage in CAPD: are they related?","volume":"22","author":"De Vecchi","year":"2002","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.nephro.2015.12.006_bib0110","first-page":"832","article-title":"Increased incidence of hydrothorax complicating peritoneal dialysis in patients with adult polycystic kidney disease","volume":"9","author":"Fletcher","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.12.006_bib0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/089686080402400113","article-title":"A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis","volume":"24","author":"Pandya","year":"2004","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.nephro.2015.12.006_bib0120","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/bjs.1800840509","article-title":"Abdominal wall hernia in autosomal dominant polycystic kidney disease","volume":"84","author":"Morris-Stiff","year":"1997","journal-title":"Br J Surg"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725516300372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725516300372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2015.12.006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:28:04Z","timestamp":1741192084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725516300372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1769725516300372"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2015.12.006","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is peritoneal dialysis a therapeutic option for polycystic kidney disease? 15\u00a0years\u2019 experience in a single center","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2015.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Association Soci\u00e9t\u00e9 de n\u00e9phrologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}